Cargando…

Direct Healthcare Cost of Obesity in Brazil: An Application of the Cost-of-Illness Method from the Perspective of the Public Health System in 2011

BACKGROUND: Obesity is a global public health problem and a risk factor for several diseases that financially impact healthcare systems. OBJECTIVE: To estimate the direct costs attributable to obesity (body mass index {BMI} ≥ 30 kg/m(2)) and morbid obesity (BMI ≥ 40 kg/m(2)) in adults aged ≥ 20 incu...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Michele Lessa, Santos, Leonor Maria Pacheco, da Silva, Everton Nunes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382114/ https://www.ncbi.nlm.nih.gov/pubmed/25830909 http://dx.doi.org/10.1371/journal.pone.0121160

Ejemplares similares

RETRACTED ARTICLE: Direct healthcare costs of spinal disorders in Brazil
por: Luiz Carregaro, Rodrigo, et al.
Publicado: (2018)

Cost of providing doctors in remote and vulnerable areas: Programa Mais Médicos in Brazil
por: da Silva, Everton Nunes, et al.
Publicado: (2018)

Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil
por: Milani, Vanessa, et al.
Publicado: (2021)

Prevented cases of neural tube defects and cost savings after folic acid fortification of flour in Brazil
por: Rodrigues, Viviane Belini, et al.
Publicado: (2023)

Direct and indirect costs attributed to alcohol consumption in Brazil, 2010 to 2018
por: de Freitas, Mariana Gonçalves, et al.
Publicado: (2022)

Cost-effectiveness of mandatory folic acid fortification of flours in prevention of neural tube defects: A systematic review
por: Rodrigues, Viviane Belini, et al.
Publicado: (2021)

Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study
por: Toscano, Cristiana M., et al.
Publicado: (2018)

Direct from the COVID-19 crisis: research and innovation sparks in Brazil
por: Rosa, Mário Fabrício Fleury, et al.
Publicado: (2021)

Cost of Illness of Tuberculosis in Tehran in the Year 2011
por: Hasoumi, Mojtaba, et al.
Publicado: (2014)

Low back pain should be considered a health and research priority in Brazil: Lost productivity and healthcare costs between 2012 to 2016
por: Carregaro, Rodrigo Luiz, et al.
Publicado: (2020)

Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines
por: Vieira Machado, Alessandra A., et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Influenza A (H1N1) Chemoprophylaxis in Brazil
por: Vecoso, Luisa von Zuben, et al.
Publicado: (2019)

An assessment of direct and indirect costs of dementia in Brazil
por: Ferretti, Ceres, et al.
Publicado: (2018)

Direct and Indirect Costs of Diabetes in Brazil in 2016
por: Pereda, Paula, et al.
Publicado: (2022)

The direct and indirect costs of cardiovascular diseases in Brazil
por: de Araújo, Jevuks Matheus, et al.
Publicado: (2022)

Direct cost of systemic arterial hypertension and its complications in the circulatory system from the perspective of the Brazilian public health system in 2019
por: Curado, Daniel da Silva Pereira, et al.
Publicado: (2021)

Economic costs of obesity in Thailand: a retrospective cost-of-illness study
por: Pitayatienanan, Paiboon, et al.
Publicado: (2014)

Direct costs of prematurity and factors associated with birth and maternal conditions
por: de Melo, Thamires Francelino Mendonça, et al.
Publicado: (2022)

Clinical outcomes and healthcare costs of inpatients with tetanus in Korea, 2011–2019
por: Bae, Sohyun, et al.
Publicado: (2021)

Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil
por: Carvalho, Janaína de Pina, et al.
Publicado: (2021)

Hypertension in the South African public healthcare system: a cost-of-illness and burden of disease study
por: Kohli-Lynch, Ciaran N, et al.
Publicado: (2022)

Social Cost of Leptospirosis Cases Attributed to the 2011 Disaster Striking Nova Friburgo, Brazil
por: Pereira, Carlos, et al.
Publicado: (2014)

Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of-illness analysis
por: Maltezou, H.C., et al.
Publicado: (2021)

The Cost-Variation Index for 2011
Publicado: (2010)

The Cost-Variation Index for 2011
Publicado: (2010)

Real world data study of prevalence and direct costs related to dengue management in Brazil's private healthcare from 2015 to 2020
por: Abud, Denise Alves, et al.
Publicado: (2022)

Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System
por: Goncalves, Gabriela Maria Reis, et al.
Publicado: (2018)

1552. Clinical Outcomes and Healthcare Costs of Inpatients with Tetanus in Korea in 2011–2019
por: Bae, Sohyun, et al.
Publicado: (2020)

Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study
por: Alshamsi, Shaikha, et al.
Publicado: (2022)

Estimating the healthcare cost of overweight and obesity in South Africa
por: Boachie, Micheal Kofi, et al.
Publicado: (2022)

Outpatient healthcare costs associated with overweight and obesity in Italy
por: Atella, Vincenzo, et al.
Publicado: (2023)

Canadian Potential Healthcare and Societal Cost Savings from Consumption of Pulses: A Cost-Of-Illness Analysis
por: Abdullah, Mohammad M. H., et al.
Publicado: (2017)

Information on the Cost-Variation Index for 2011
Publicado: (2010)

Information on the Cost-Variation Index for 2011
Publicado: (2010)

Cost of illness for outpatients attending public and private hospitals in Bangladesh
por: Pavel, Md Sadik, et al.
Publicado: (2016)

Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil
por: Ubels, Jasper, et al.
Publicado: (2020)

Direct Healthcare Cost of Ischemic Stroke Management in Morocco
por: Omari, Mohammed, et al.
Publicado: (2023)

The economic burden of obesity in Italy: a cost-of-illness study
por: d’Errico, Margherita, et al.
Publicado: (2021)

Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
por: Carvalho, Viviane Karoline da Silva, et al.
Publicado: (2019)

The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals
por: Hong, Jiyeon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_40hdfc3rf0o5bf13lka41e96cs